SCHEMBL7473050

SCHEMBL7473050

Cc1cc(CBr)cc(NC(=O)OC(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.42
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA9 Q16790 1/20 0.40
TOP2A P11388 1/20 0.40
TOP2B Q02880 1/20 0.40
HDAC8 Q9BY41 2/20 0.39
LCK P06239 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
MAPK14 Q16539 1/20 0.38
KMT2A Q03164 1/20 0.37
AKT1 P31749 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15858111 0.91 CYP17A1 (0.46) CYP17A1CA12CA1CA9TOP2A
SCHEMBL6296543 0.87 CYP17A1 (0.43) CYP17A1CA12CA1CA9TOP2A
SCHEMBL7477384 0.84 CA12 (0.48) CYP17A1CA12CA1CA9HDAC8
SCHEMBL15077304 0.83 CYP17A1 (0.40) CYP17A1CA12CA1CA9TOP2A
SCHEMBL26162760 0.83 CYP17A1 (0.40) CYP17A1CA12CA1CA9TOP2A
SCHEMBL22480889 0.82 KDM4E (0.50) CYP17A1TOP2ATOP2BHDAC8LCK
SCHEMBL15077302 0.81 HRH3 (0.41) CYP17A1CA12CA1CA9TOP2A
SCHEMBL13833174 0.80 LCK (0.44) CYP17A1CA12CA1CA9HDAC8
SCHEMBL30632213 0.79 AURKA (0.49) CYP17A1CA12CA1CA9HDAC8
SCHEMBL1865895 0.79 AURKA (0.49) CYP17A1CA12CA1CA9HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4006033-A1 ADENOSINE RECEPTOR ANTAGONIST Xiamen Biotime Biotechnology Co., Ltd. (CN) 2022-06-01 EP disclosed
WO-2021018173-A1 ADENOSINE RECEPTOR ANTAGONIST 杭州阿诺生物医药科技有限公司 2021-02-04 WO disclosed
EP-0930298-B1 FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMA CO LTD (JP) 2002-12-18 EP disclosed
US-6040449-A USEFUL FOR FORMING FLUORINE CONTAINING 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES, USEFUL AS ANTAGONIST FOR MUSCARINIC M3 RECEPTORS AND LESS SIDE EFFECT BANYU PHARMACEUTICAL CO LTD (JP) 2000-03-21 US disclosed
US-5948792-A POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-09-07 US disclosed
EP-0930298-A1 FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-07-21 EP disclosed